WHO guideline for screening and treatment of cervical pre-cancer lesions for cervical cancer prevention: Use of mRNA tests for human papillomavirus (HPV) [Internet]
- PMID: 35044737
- Bookshelf ID: NBK576615
WHO guideline for screening and treatment of cervical pre-cancer lesions for cervical cancer prevention: Use of mRNA tests for human papillomavirus (HPV) [Internet]
© World Health Organization 2021.
Sections
- Acknowledgements
- Acronyms and abbreviations
- Executive summary
- 1. Introduction
- 2. Methods for development of recommendations on HPV mRNA testing
- 3. Recommendations on HPV mRNA testing
- 4. Research gaps and further considerations for HPV mRNA testing
- 5. Dissemination and updating of the guideline
- References
- Annex 1. Guideline groups
- Annex 2. Evidence-gathering teams and guideline task groups
- Annex 3. Declarations of interests
- Annex 4. Algorithms for use of HPV mRNA tests in the general population of women
- Annex 5. Recommendations from Phase 1 of the guideline update: HPV DNA tests and other cervical screening methods
- Web Annex. Evidence-to-decision framework for mRNA testing for HPV
Publication types
LinkOut - more resources
Full Text Sources